Pfizer Zyrtec-D Indicated For Allergic Rhinitis In Patients 12 And Older
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer’s antihistamine/decongestant combination tablet Zyrtec-D 12 Hour (cetirizine 5 mg/pseudoephedrine 120 mg) cleared FDA Aug. 10 "for relief of nasal and non-nasal symptoms associated with seasonal or perennial allergic rhinitis in adults and children 12 years of age and older."